Dr Eric Tichy Calls for Government Officials to Realign Incentives in Favor of BiosimilarsMay 18th 2022
Altering reimbursement procedures needs to become a bigger priority for government officials to incentivize biosimilar utilization, according to Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary at the Mayo Clinic Health System.
Conference Posters Highlight Real-world Trends of Biosimilars, Reclassified BiologicsMay 14th 2022
Posters from the Academy of Managed Care Pharmacy (AMCP)’s annual meeting examined the real-world patterns of biosimilar utilization and the impact of products that have been reclassified as biologics on Medicaid spending.
Amid Good Signs on Biosimilars, COVID-19 Upends Drug Purchasing PatternsApril 20th 2020
Douglas M. Long, MBA, vice president of Industry Relations for IQVIA, surveyed COVID-19's effects on the pharmaceutical marketplace as he kicked off AMCP eLearning Days, a webinar series held in place of the annual meeting of the Academy of Managed Care Pharmacy (AMCP).
Ruby Singh Previews the AMCP eLearning Days Virtual MeetingApril 17th 2020
Ruby Singh, vice president for Education and Training, Academy of Managed Care Pharmacy (AMCP), speaks with Mary Caffrey about the upcoming AMCP eLearning Days, a virtual meeting that will take place April 20 to 24. AMCP's annual meeting was canceled due to coronavirus disease 2019 (COVID-19). This transcript is edited slightly for clarity.